Clinical trial
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 is registered in ClinicalTrials.gov with St. Claraspital AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
- Lead sponsor
- St. Claraspital AG
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- April 30, 2005
- Completion date
- April 1, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer